Riederer, Peter

Influence of neuromelanin on oxidative pathways within the human substantia nigra

Double, K. L., Ben-Shachar, D., Youdim, M. B. H., Zecca, L., Riederer, P., & Gerlach, M. (2002) · Neurotoxicology and Teratology

Parkinson's Disease Mechanisms and Treatmentsmelanin and skin pigmentation

Cited by 102

Homospecific activity (activity per enzyme protein) of tyrosine hydroxylase increases in parkinsonian brain

Mogi, M., Harada, M., Kiuchi, K., Kojima, K., Kondo, T., Narabayashi, H., Rausch, D., Riederer, P., Jellinger, K., & Nagatsu, T. (1988) · Journal of Neural Transmission

Parkinson's Disease Mechanisms and TreatmentsNuclear Receptors and Signaling

Cited by 101

Altered redox state of platelet coenzyme Q 10 in Parkinson's disease

Götz, M. E., Gerstner, A., Harth, R., Dirr, A., Janetzky, B., Kuhn, W., Riederer, P., & Gerlach, M. (2000) · Journal of Neural Transmission

Coenzyme Q10 studies and effectsParkinson's Disease Mechanisms and Treatments

Cited by 93

Increased brain levels of 4-hydroxy-2-nonenal glutathione conjugates in severe Alzheimer’s disease

Völkel, W., Sicilia, T., Pähler, A., Gsell, W., Tatschner, T., Jellinger, K., Leblhuber, F., Riederer, P., Lutz, W. K., & Götz, M. E. (2006) · Neurochemistry International

Alzheimer's disease research and treatmentsAntioxidant Activity and Oxidative Stress

Cited by 76

The neuronal calcium sensor protein VILIP-1 is associated with amyloid plaques and extracellular tangles in Alzheimer’s disease and promotes cell death and tau phosphorylation in vitro: a link between calcium sensors and Alzheimer’s disease?

Schnurra, I., Bernstein, H.-G., Riederer, P., & Braunewell, K.-H. (2001) · Neurobiology of Disease

Alzheimer's disease research and treatmentsS100 Proteins and Annexins

Cited by 76

Memantine upregulates BDNF and prevents dopamine deficits in SIV-infected macaques: a novel pharmacological action of memantine

for the German Competence Network HIV/AIDS, Meisner, F., Scheller, C., Kneitz, S., Sopper, S., Neuen-Jacob, E., Riederer, P., Meulen, V. T., & Koutsilieri, E. (2008) · Neuropsychopharmacology

HIV Research and TreatmentHIV/AIDS drug development and treatment

Cited by 73

Inflammatory Pathways in Parkinson’s Disease; A BNE Microarray Study

Durrenberger, P. F., Grünblatt, E., Fernando, F. S., Monoranu, C. M., Evans, J., Riederer, P., Reynolds, R., & Dexter, D. T. (2012) · Parkinson's Disease

Parkinson's Disease Mechanisms and TreatmentsNeuroinflammation and Neurodegeneration Mechanisms

Cited by 63

Diabetes type II: A risk factor for depression-Parkinson–Alzheimer?

Riederer, P., Bartl, J., Laux, G., & Grünblatt, E. (2011) · Neurotoxicity Research

Stress Responses and CortisolParkinson's Disease Mechanisms and Treatments

Cited by 51

Neuromelanin-bound ferric iron as an experimental model of dopaminergic neurodegeneration in Parkinson's disease

Gerlach, M., Riederer, P., & Double, K. L. (2008) · Parkinsonism & Related Disorders

Parkinson's Disease Mechanisms and TreatmentsNeurological diseases and metabolism

Cited by 33

Effects of methylphenidate: the cellular point of view

Bartl, J., Link, P., Schlosser, C., Gerlach, M., Schmitt, A., Walitza, S., Riederer, P., & Grünblatt, E. (2010) · ADHD Attention Deficit and Hyperactivity Disorders

Attention Deficit Hyperactivity DisorderNeurotransmitter Receptor Influence on Behavior

Cited by 29

Brain aging phenomena in migrating sockeye salmon Oncorhynchus nerka nerka

Götz, M. E., Malz, C. R., Dirr, A., Blum, D., Gsell, W., Schmidt, S., Burger, R., Pohli, S., & Riederer, P. (2005) · Journal of Neural Transmission

Genetics, Aging, and Longevity in Model OrganismsReproductive biology and impacts on aquatic species

Cited by 11